Inventor
BAKER DARREN J
US13 patents
⚠️ This page may combine multiple inventors who share the name “BAKER DARREN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BUCK INST RES AGING
7 patentsUS10010546B2Jul 3, 2018
Treatment of ophthalmic conditions by selectively removing senescent cells from the eye
BUCK INST RES AGING23 citations97
US10478432B2Nov 19, 2019
Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye
BUCK INST RES AGING7 citations92
US10258618B2Apr 16, 2019
Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen
BUCK INST RES AGING5 citations84
US9980962B2May 29, 2018
Use of sulfonamide inhibitors of Bcl-2 to treat senescence-associated lung conditions such as pulmonary fibrosis and chronic obstructive pulmonary disease
BUCK INST RES AGING6 citations84
US10413542B2Sep 17, 2019
Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase
BUCK INST RES AGING4 citations83
US11351167B2Jun 7, 2022
Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue
BUCK INST RES AGING1 citations73
US11963957B2Apr 23, 2024
Treating cardiovascular disease by selectively eliminating senescent cells
BUCK INST RES AGING0 citations72
MAYO FOUND MEDICAL EDUCATION & RES
3 patentsUS9968076B2May 15, 2018
Transgenic animals capable of being induced to delete senescent cells
MAYO FOUND MEDICAL EDUCATION & RES19 citations93
US10328058B2Jun 25, 2019
Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
MAYO FOUND MEDICAL EDUCATION & RES5 citations72
US10251376B2Apr 9, 2019
Increasing healthy lifespan and delaying progression of age-related phenotypes by selectively removing senescent cells
MAYO FOUND MEDICAL EDUCATION & RES0 citations51
UNITY BIOTECHNOLOGY INC
3 patentsUS10328073B2Jun 25, 2019
Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells
UNITY BIOTECHNOLOGY INC9 citations92
US10517866B2Dec 31, 2019
Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor
UNITY BIOTECHNOLOGY INC5 citations83
US10478433B2Nov 19, 2019
Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss
UNITY BIOTECHNOLOGY INC4 citations83